Michael Mansour
Assistant Professor of Medicine at Harvard Medical School · Beth Israel Deaconess Medical Center
Credentials: · · · · ·
History
Research
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
New England Journal of Medicine · 2020 · 1,045 citations
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Case report · New England Journal of Medicine · 2019 · 1,001 citations
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Science · 2010 · 997 citations
30 papers
- DS
19 papers
- JR
14 papers · 2 as a fellow
12 papers
10 papers · 8 as a resident
- PN
9 papers · 2 as a resident
- DS
6 papers
5 papers · 2 as a fellow
Grants
- 2023–2028
In vivo Monitoring of Neutrophil Function in Patients After Stem Cell Transplant
National Institute of Allergy and Infectious Diseases · R01
PI · $3.2M · Massachusetts General Hospital
- 2018–2024
The Role of Spleen Tyrosine Kinase (Syk) in Neutrophil Responses to Pathogenic Fungi.
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.6M · Massachusetts General Hospital
- 2014–2019
Subcellular Mechanisms for Fungal Phagosome Maturation in Macrophages
National Institute of Allergy and Infectious Diseases · K08
Contact PI · $759.1K · Massachusetts General Hospital
Clinical trials
- 2020–2023
Principal investigator · Completed
Massachusetts General Hospital